NEW YORK , Jan. 15, 2021 /PRNewswire/ -- As the City continues to fight the winter surge of COVID-19 cases, the NYC Test & Trace Corps today announced the expansion of its partnership with Rapid ...

Ambulnz has administered about 25,000 vaccines and completed nearly 1.2 million tests through its unit, Rapid Reliable Testing, its website showed. Motion Acquisition raised $115 million when it ...

Rapid Reliable Testing, part of Midtown-based health care company Ambulnz by DocGo, operates the Street Health Outreach and Wellness Program’s mobile units that are deployed in neighborhoods ...

DocGo's mobile health services business is rapidly growing with revenue expected to hit $43 million in 2021, up from just $2 million in 2020, company executives said. "Both businesses have plenty ...

About The Future DocGo: Founded in 2015, Ambulnz has a network of over 1,700 paramedics and EMTs that provide testing, vaccination, bloodwork, IV/hydration, wound care and mobile imaging.

The mobile health contracts include COVID-19 testing, COVID-19 vaccine programs, and at-home monoclonal antibody infusion treatments to eligible patients across the state of Nevada.

Mobile units provide wound care, physical assessments, vaccinations, and other critical services. NEW YORK, July 1, 2021 /PRNewswire/ -- The NYC Test & Trace Corps and DocGo, a leading provider of ...

“Our mobile health services, robust technology and multi-regional presence put us in a unique position to help businesses with COVID-19 vaccinations, testing and OSHA compliance,” said Anthony ...

Mobile medical services provider Ambulnz will go public through a merger with a special purpose acquisition company (SPAC) in a deal that values the equity of the merged entity at $1.1 billion ...

A company specializing in last mile telehealth and medical mobility services is going public in a SPAC deal announced Tuesday. The SPAC Deal: Ambulnz is going public in a $1.1 billion deal with ...